CVS HEALTH Corp: Form 10-Q for the period ended Mar 31, 2010
Filed with the SEC on May 4, 2010 and accepted by EDGAR at May 4, 2010, 16:31 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2010-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2010-01-01 to 2010-03-31 | $23.76bn | us-gaap:Revenues |
| Cost of revenue | 3 months2010-01-01 to 2010-03-31 | $19.01bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months2010-01-01 to 2010-03-31 | $4.75bn | us-gaap:GrossProfit |
| Operating income | 3 months2010-01-01 to 2010-03-31 | $1.41bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2010-01-01 to 2010-03-31 | $510.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2010-01-01 to 2010-03-31 | $771.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2010-01-01 to 2010-03-31 | $0.55 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2010-01-01 to 2010-03-31 | $0.56 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2010-01-01 to 2010-03-31 | 1,396,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2010-01-01 to 2010-03-31 | $1.06bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2010-01-01 to 2010-03-31 | $401.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2010-01-01 to 2010-03-31 | $122.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months2010-01-01 to 2010-03-31 | $887.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2010-03-31 | $1.05bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2010-03-31 | $17.16bn | us-gaap:AssetsCurrent |
| Total assets | At period end2010-03-31 | $61.28bn | us-gaap:Assets |
| Current liabilities | At period end2010-03-31 | $12.34bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2010-03-31 | $8.45bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2010-03-31 | $2.40bn | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2010-03-31 | $515.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2010-03-31 | $35.69bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-10-106601. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.